Myonex Acquires Clinical Trial and Drug Wholesale Business of Hubertus in Berlin


Myonex has announced entry into a definitive agreement with the owners of Hubertus Apotheke am Salzufer (“Hubertus”) to acquire the Clinical Trial and Wholesale Drug Business, located in Berlin, Germany. Myonex and the owners of Hubertus also have entered a cooperation agreement with the remaining Pharmacy Business of Hubertus to support decentralized clinical trials (DCTs). The closing of the acquisition is expected to occur in coming months after completion of the appropriate regulatory licensing approvals.

Read more about the acquisition here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.